Company Filing History:
1 out of 832,812 Years Active: 2010
Title: Riitta Lahesmaa: Innovator in Immune-Mediated Disease Research
Introduction
Riitta Lahesmaa is a prominent inventor based in Turku, Finland. She has made significant contributions to the field of immunology, particularly in understanding immune-mediated diseases. Her innovative work has led to the development of methods that utilize novel target genes related to conditions such as asthma, allergies, and autoimmune diseases.
Latest Patents
Riitta Lahesmaa holds 1 patent for her invention titled "Methods utilizing target genes related to immune-mediated diseases." This invention provides methods based on a molecular level description of the polarization of CD4+ precursor cells, which are crucial for the development of T helper cells. The patent outlines a method for identifying compounds that can modulate the polarization of CD4+ lymphocytes. Additionally, it includes a method for assessing the presence of, or predisposition to, immune-related disorders in subjects.
Career Highlights
Throughout her career, Riitta has focused on advancing the understanding of immune responses and their implications for various diseases. Her research has been instrumental in identifying potential therapeutic targets for immune-mediated conditions.
Collaborations
Riitta has collaborated with notable colleagues, including Riikka Lund and Zhi David Chen, to further her research initiatives and enhance the impact of her work in the scientific community.
Conclusion
Riitta Lahesmaa's innovative contributions to the field of immunology highlight her dedication to improving the understanding and treatment of immune-mediated diseases. Her work continues to inspire advancements in medical research and therapeutic development.